Identifying factors affecting upper limb function after breast cancer treatment
Official title: Identifying Prognostic Variables for Persistent Upper Limb Dysfunctions After Breast Cancer Treatment: Longitudinal Cohort Study
Run by KU Leuven · NCT05371847 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study looks at what might be causing ongoing arm problems in breast cancer survivors after treatment to help improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven) |
| Trial ID | NCT05371847 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include breast cancer patients scheduled for surgery and those receiving adjuvant radiotherapy.
✕Probably not a fit
Patients with widespread metastases or those who have undergone previous breast surgery may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to identify prognostic variables that contribute to persistent upper limb dysfunctions in breast cancer survivors following treatment. It focuses on assessing upper limb function in patients who have undergone surgery and adjuvant radiotherapy for breast cancer. By understanding these factors, the study seeks to improve the quality of life for breast cancer survivors by addressing barriers to physical activity caused by upper limb dysfunction. The methodology includes assessments and retests to evaluate upper limb function over time.
Why it matters
Potential benefit: If successful, this study could lead to improved interventions that enhance upper limb function and overall quality of life for breast cancer survivors.
How similar studies have gone: Other studies have shown success in identifying factors affecting quality of life in breast cancer survivors, suggesting that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for breast cancer patients * Patients scheduled for surgery (mastectomy or breast conserving surgery; in combination with axillary lymph node dissection or sentinel node biopsy) for unilateral primary breast cancer or patients with oligometastatic breast cancer. * Patients who receive adjuvant radiotherapy . * Patients with a cognitive and language functioning enabling coherent Dutch communication between the examiner and the participant * Patients who can comply with the protocol at baseline assessment and willing to provide written informed consent Inclusion criteria healthy volunteers * Healthy women and men(quickDASH\<15) age- and gender-matched with a breast cancer patient from the main study * Volunteers who can comply with the protocol at baseline assessment and willing to provide written informed consent Exclusion Criteria breast cancer patients * BCS with widespread distance metastases, previous breast surgery, or planned bilateral surgery * And/or with a diagnosis of a neurological or rheumatological condition, diabetes, * And/or BCS who are not available the entire duration of the study Exclusion Criteria healthy volunteers * History of breast cancer * Patients with a diagnosis of neurological or rheumatological condition, diabetes
Where it's running
-
Universitair Ziekenhuis Leuven
Leuven, Belgium Recruiting
Study contacts
- Principal investigator: An De Groef, Prof. Dr. — KU Leuven
- Study coordinator: An De Groef, Prof. Dr.
- Email: an.degroef@kuleuven.be
- Phone: 003216376668
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.